Irish Jian
See Remarks
Irish Jian has filed 6 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 10, 2026.
On the most recent filing, Irish Jian is listed as See Remarks at Metagenomi Therapeutics, Inc. Inside the rolling window, Irish Jian reported no open-market purchases and 5 open-market sales totaling $16K in MGX. The largest disclosed transaction in the window is a sale of 3,737 MGX shares on Jun 5, 2026, worth $5K.
Companies traded
Other insiders at MGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Irish Jian made?
Irish Jian has filed 6 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Irish Jian trade?
Irish Jian has filed SEC Form 4 disclosures for 1 company, including MGX.
When was Irish Jian's most recent SEC Form 4 filing?
Irish Jian's most recent SEC Form 4 filing on Tracefour is dated Sep 10, 2026.
What is Irish Jian's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Irish Jian is listed as See Remarks.
What is Irish Jian's total buy and sell value in the current window?
Inside the rolling retention window, Irish Jian bought $0 and sold $16K based on SEC Form 4 filings.
What was Irish Jian's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,737 MGX shares on 2026-06-05, worth $5K, per SEC Form 4 filings.